PHENYLEPHRINE HYDROCHLORIDE
| Brand name | PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE |
|---|---|
| Active ingredient | PHENYLEPHRINE HYDROCHLORIDE |
| Strength | 20MG/250ML (0.08MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | May 2025 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12564561 | August 2044 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.